Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 Trial

Yan Zhao(Peking University), Jianzhong Zhang(Peking University), Chao Ji(Zhongshan Hospital of Xiamen University), Bin Yang(Southern Medical University), Qingchun Diao(Beijing University of Chinese Medicine), Xiaohua Tao(Zhejiang Provincial People's Hospital), Tao Cai(Third Xiangya Hospital), Rong Xiao(Tongji University), Qianjin Lu(Central South University), Fuqiu Li(Second Affiliated Hospital of Jilin University), Yudian Qiu(Peking University), Liming Wu(Hangzhou First People's Hospital), Xiao‐Yong Man(Second Affiliated Hospital of Zhejiang University), Lihua Wang(Jinan Central Hospital), Linfeng Li(Beijing Tongren Hospital), Jinyan Wang(Ningbo No. 2 Hospital), Bo Chen(Hunan Children's Hospital), Xiaohong Zhu(Shanxi Medical University), Yumei Li(Jiangsu University), Yanyan Feng(Shanghai Jiao Tong University), Litao Zhang(Tianjin University of Traditional Chinese Medicine), Chao Liang(Chengdu Medical College), Hong Ren(The First People’s Hospital of Lianyungang), Jianyun Lu(Central South University), Jingyi Li(Sichuan University), Huiming Zeng(Hainan Medical University), Qing Sun(Qilu Hospital of Shandong University)
Advances in Therapy
July 12, 2025
Cited by 3


Related Papers